Press Events

Scientists in Germany have discovered that colon cancers contain two different cell types, characterized by mitogen-activated protein kinase (MAPK) and NOTCH signaling, respectively, which can regenerate each other when one type is killed by a targeted therapeutic. The studies, headed by David Horst, Ph.D., at the Charité University Hospital in Berlin, suggest that this cellRead more

Brown University researchers studying the biology of aging have demonstrated a new strategy for stimulating autophagy, the process by which cells rebuild themselves by recycling their own worn-out parts.   In a study (“Nuclear Export Inhibition Enhances HLH-30/TFEB Activity, Autophagy, and Lifespan”), published in Cell Reports, the team shows that the approach increased the lifespans of wormsRead more

With close to 50% of the world’s population living in areas endemic to malaria and almost half a million malaria deaths per year, identifying asymptomatic carriers of this parasitic infection is a critical factor for lowering disease transmission rates. However, standard tests often miss identifying carriers, especially when parasitemias are low. Moreover, while DNA testsRead more

An international team of researchers has linked a gene known as peptidase M20-domain-containing protein 1 (PM20D1) with Alzheimer’s disease (AD) in humans. An analysis of genetic and epigenetic study data, combined with data from human tissue samples and subsequent experiments in mouse models, indicated that increased levels of PM20D1 in the brain have a protectiveRead more

  The 2018 BIO International Conference (BIO) will take place in Boston, MA from June 4-7.  The BIO attracts 16,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships.   Our CEO, Dr. Chunlin Chen will attend the conference along with our Directors ofRead more